4
Changes in Ownership
Neurogene Inc. Filed Acc 0001968554-26-000005
Chief Medical Officer sold 828 shares at $21.89 ($18,128)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jordan Julie Chief Medical Officer | 2026-03-26 | Sale 10b5-1 | −828 | $21.89 | $18,128 | 12,472 | D: show line 1 in the form |
| Open-market sales · 828 sh · avg $21.89 · $18,128 | |||||||
Loading xslF345X06/wk-form4_1774905406.xml…